Journal article
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry
Abstract
Aims: The aims of the present study were to describe the proportion of patients eligible for the COMPASS trial within the Reduction of Atherothrombosis for Continued Health (REACH) registry, the reasons for ineligibility, and to put in perspective the characteristics and outcomes of trial-eligible patients from the REACH registry compared with those of patients enrolled in the reference aspirin arm of the COMPASS trial.
Methods and results: The …
Authors
Darmon A; Bhatt DL; Elbez Y; Aboyans V; Anand S; Bosch J; Branch KR; Connolly SJ; Dyal L; Eikelboom JW
Journal
European Heart Journal, Vol. 39, No. 9, pp. 750–757a
Publisher
Oxford University Press (OUP)
Publication Date
March 1, 2018
DOI
10.1093/eurheartj/ehx658
ISSN
0195-668X